RACHEL TETI: Open Payments
NPI 1801364583 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 22 payments from 7 companies in 2025. Trend: 2023 $393 · 2024 $407 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $145 |
| Optinose US, Inc. | 4 | $90 |
| GENZYME CORPORATION | 4 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: NUCALA, Xhance, DUPIXENT, TEZSPIRE, UBRELVY.
Industry payments across PA — which companies pay providers there.
